Locations:
Search IconSearch
April 18, 2022/Neurosciences/Podcast

Use of Ketamine to Treat Chronic Pain (Podcast)

IV ketamine infusion is an option when conventional therapies fail to yield relief


Approximately 20% of U.S. adults experience chronic pain, according to the Centers for Disease Control and Prevention. During the past two decades, intravenous ketamine infusion has gained popularity as a treatment option for patients with the most refractory cases.

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

“If a patient has tried conventional treatments — such as medications, injections, surgery, pain psychology, pain rehabilitation programs — and their pain persists, then ketamine may be a good option,” says Pavan Tankha, DO, an anesthesiologist and pain management physician who serves as Medical Director of the Center for Comprehensive Pain Recovery in Cleveland Clinic’s Neurological Institute.

In the most recent episode of Cleveland Clinic’s Neuro Pathways podcast, Dr. Tankha talks about the use of ketamine to manage refractory chronic pain. He delves into:

  • The history of ketamine and how it became a pain management treatment
  • Patient selection and administration of ketamine infusion
  • Contraindications and potential side effects
  • The risk of addiction to ketamine
  • What constitutes a positive response to treatment

Click the podcast player above to listen to the 25-minute episode now, or read on for a short edited excerpt. Check out more Neuro Pathways episodes at clevelandclinic.org/neuropodcast or wherever you get your podcasts.

This activity has been approved for AMA PRA Category 1 Credit™. After listening to the podcast, you can claim your credit here.

Excerpt from the episode

Podcast host Glen Stevens, DO, PhD: Are there certain chronic pain conditions for which ketamine works better than for others?

Dr. Tankha: Very good question. So, the literature for ketamine and pain is somewhat limited. Because of that, if you go based on simply the literature, the most extensively studied pain state is complex regional pain syndrome, where ketamine has been shown to have a modest benefit. Other neuropathic pain states, such as phantom limb and spinal cord injury, have some data to suggest it may work. Nociceptive pain pathways, such as osteoarthritis and rheumatoid arthritis, have limited to no data.

Advertisement

Anecdotally, based on my own experience, I’ve found that ketamine can potentially help with these conditions, but because we don’t really understand how it works, we can’t choose the appropriate candidates all the time. But given its good safety profile, I recommend giving it a try if you have exhausted other methods.

Dr. Stevens: When you give ketamine, where do you do it? What is the administration like?

Dr. Tankha: We are fortunate to have the capabilities on Cleveland Clinic’s main campus [in an infusion suite]. … It is done over a five-day period, Monday through Friday. You come in, we start an IV and we run the ketamine through your bloodstream for approximately 40 minutes. At the end of the infusion, we give you some fluids just to wash it out of your system. And then you can go home. Because ketamine is a general anesthetic, you need someone to take you back home. Some patients get a little loopy, some patients don’t feel anything. But just to be on the safe side, we ask that someone take the patient home.

Advertisement

Related Articles

woman deeply breathing  on a white couch
Brief Biofeedback Protocol Improves Stress and Mood Outcomes in Multiple Sclerosis

Study shows short-term behavioral training can yield objective and subjective gains

woman at desk with earphones smiling at computer screen
January 20, 2026/Neurosciences/Brain Health
Using Shared Medical Appointments to Inform Decisions on Anti-Amyloid Therapy for Alzheimer’s Disease

How we’re efficiently educating patients and care partners about treatment goals, logistics, risks and benefits

Dr. Deepak Lachhwani against a decorative background with a podcast icon overlay
January 16, 2026/Neurosciences/Podcast
How Epilepsy Care Changes as Pediatric Patients Grow (Podcast)

An expert’s take on evolving challenges, treatments and responsibilities through early adulthood

small child walking with a wheeled walker
January 15, 2026/Neurosciences/Epilepsy
Developmental and Epileptic Encephalopathies: Insights From a Large Pediatric Series

Comorbidities and medical complexity underlie far more deaths than SUDEP does

woman in white medical coat talking with another woman in front of a computer screen
January 13, 2026/Neurosciences/Epilepsy
New Program Tackles Dual Challenge of Epilepsy and Dementia in Older Adults

Novel Cleveland Clinic project is fueled by a $1 million NIH grant

Image of Dr. Foldvary-Schaefer
January 2, 2026/Neurosciences/Podcast
Sleep Self-Screening Is Just an App Away (Podcast)

Tool helps patients understand when to ask for help

two brain images with colored dots and red line overlays
December 18, 2025/Neurosciences/Brain Health
Can Cognitive Fluctuations Offer Insight Into Alzheimer’s Disease Neurobiology?

Large NIH-funded investigation is exploring this understudied phenomenon

Dr. Andrew Dhawan against a decorative background with podcast icon overlay
December 16, 2025/Neurosciences/Podcast
Emerging Technologies in Brain Tumor Management (Podcast)

Advances in genomics, spinal fluid analysis, wearable-based patient monitoring and more

Ad